000			02119 a2200673 4500
005			20250513145606.0
264		0	_c19980803
008			199808s 0 0 eng d
022			_a0022-2623
024	7		_a10.1021/jm980068d _2doi
040			_aNLM _beng _cNLM
100	1		_aDragovich, P S
245	0	0	_aStructure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 1. Michael acceptor structure-activity studies. _h[electronic resource]
260			_bJournal of medicinal chemistry _cJul 1998
300			_a2806-18 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article
650	0	4	_a3C Viral Proteases
650	0	4	_aAnimals
650	0	4	_aAntiviral Agents _xchemical synthesis
650	0	4	_aBinding Sites
650	0	4	_aCell Line, Transformed
650	0	4	_aCrystallography, X-Ray
650	0	4	_aCysteine Endopeptidases _xchemistry
650	0	4	_aCysteine Proteinase Inhibitors _xchemical synthesis
650	0	4	_aDrug Design
650	0	4	_aDrug Stability
650	0	4	_aHeLa Cells
650	0	4	_aHumans
650	0	4	_aOligopeptides _xchemical synthesis
650	0	4	_aProtein Conformation
650	0	4	_aRats
650	0	4	_aRats, Sprague-Dawley
650	0	4	_aRhinovirus _xdrug effects
650	0	4	_aStructure-Activity Relationship
650	0	4	_aViral Proteins
700	1		_aWebber, S E
700	1		_aBabine, R E
700	1		_aFuhrman, S A
700	1		_aPatick, A K
700	1		_aMatthews, D A
700	1		_aLee, C A
700	1		_aReich, S H
700	1		_aPrins, T J
700	1		_aMarakovits, J T
700	1		_aLittlefield, E S
700	1		_aZhou, R
700	1		_aTikhe, J
700	1		_aFord, C E
700	1		_aWallace, M B
700	1		_aMeador, J W
700	1		_aFerre, R A
700	1		_aBrown, E L
700	1		_aBinford, S L
700	1		_aHarr, J E
700	1		_aDeLisle, D M
700	1		_aWorland, S T
773	0		_tJournal of medicinal chemistry _gvol. 41 _gno. 15 _gp. 2806-18
856	4	0	_uhttps://doi.org/10.1021/jm980068d _zAvailable from publisher's website
999			_c9633943 _d9633943